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Summary
 
Pathogenic 
 
Yersinia
 
 cause a systemic infection in mice that is dependent on the presence of a
large plasmid encoding a number of secreted virulence proteins called Yops. We previously
demonstrated that a plasmid-encoded Yop, YopJ, was essential for inducing apoptosis in cul-
tured macrophages. Here we report that YopJ is a virulence factor in mice and is important for
the establishment of a systemic infection. The oral LD
 
50
 
 for a 
 
yopJ
 
 mutant 
 
Yersinia pseudotubercu-
losis
 
 increases 64-fold compared with wild-type.
 
 
 
Although the 
 
yopJ
 
 mutant strain is able to
reach the spleen of infected mice, the mutant strain seldom reaches the same high bacterial load
that is seen with wild-type 
 
Yersinia
 
 strain and begins to be cleared from infected spleens on day
4 after infection. Furthermore, when in competition with wild-type 
 
Yersinia
 
 in a mixed infec-
tion, the 
 
yopJ
 
 mutant strain is deficient for spread from the Peyer’s patches to other lymphoid
tissue. We also show that wild-type 
 
Yersinia
 
 induces apoptosis in vivo of Mac-1
 
1
 
 cells from in-
fected mesenteric lymph nodes or spleens, as measured by quantitative flow cytometry of
TUNEL (Tdt-mediated dUTP–biotin nick-end labeling)-positive cells. The levels of Mac-1
 
1
 
,
TUNEL
 
1
 
 cells from tissue infected with the 
 
yopJ 
 
mutant strain were equivalent to the levels
detected in cells from uninfected tissue. YopJ is necessary for the suppression of TNF-
 
a
 
 pro-
duction seen in macrophages infected with wild-type 
 
Yersinia, 
 
based on previous in vitro stud-
ies (Palmer, L.E., S. Hobbie, J.E. Galan, and J.B. Bliska. 1998. 
 
Mol. Microbiol.
 
 27:953–965). We
conclude here that YopJ plays a role in the establishment of a systemic infection by inducing
apoptosis and that this is consistent with the ability to suppress the production of the proinflam-
matory cytokine tumor necrosis factor 
 
a
 
.
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T
 
he genus 
 
Yersinia
 
 includes three species that are patho-
genic for humans and rodents and carry the virulence
plasmid, pYV (1, 2). 
 
Y
 
. 
 
pestis
 
 is the causative agent of plague.
The enteropathogenic 
 
Yersinia
 
 species, 
 
Y
 
.
 
 enterocolitica
 
 and
 
Y
 
.
 
 pseudotuberculosis
 
, cause gastrointestinal syndromes, lym-
phadenitis, and septicemia (2, 3). Furthermore, systemic in-
fections can occur with formation of abscesses in the liver
and spleen as well as immunopathologic sequelae such as
reactive arthritis (4, 5).
In the experimental mouse model of infection, the bacte-
ria bind to and invade the M cells within the follicle-associ-
ated epithelium overlying the lymphoid follicles of the
Peyer’s patches (PP),
 
1
 
 which are components of the gut-
associated lymphoid tissue (6). The chromosomally-encoded
bacterial protein, invasin, and the plasmid-encoded protein,
YadA, have been shown to be involved in this binding and
subsequent entry of 
 
Yersinia
 
 to the M cells within the folli-
cle-associated epithelium (7). Once the bacteria have en-
tered the PP, they encounter the host immune cells and se-
rum factors. Two bacterial adhesins, Ail and YadA, also
play a role in promoting 
 
Yersinia
 
-mediated serum resistance
(8–10). Several virulence factors have been implicated in
the ability of 
 
Yersinia
 
 to multiply in the PP and then spread
to deeper tissues (11). Many of the genes contained on the
pYV plasmid encode proteins that comprise a host cell
contact-dependent or type III secretory pathway. The co-
ordinate activities of the secretion machinery and the ad-
herence factors allows the bacteria to translocate other
pYV-encoded proteins called Yops (12). Several Yops are
translocated into host cells where they interfere with nor-
mal cellular processes and thus enable 
 
Y
 
.
 
 pseudotuberculosis
 
and 
 
Y
 
.
 
 enterocolitica
 
 to cause systemic infections (13). YopH
 
1
 
Abbreviations used in this paper:
 
 MLNs, mesenteric lymph nodes; PP,
Peyer’s patches; TUNEL, Tdt-mediated dUTP–biotin nick-end labeling.
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Yersinia
 
 Infection
 
mediates dephosphorylation of macrophage phosphotyrosine
proteins and prevents phagocytosis (14, 15). YopH has been
shown to bind two focal adhesion proteins, p130Cas and
FAK, and destabilize focal adhesion points within mamma-
lian cells (16). YopE depolymerizes actin microfilaments
within host cells by an unknown mechanism and also plays
a role in preventing phagocytosis of Yersinia (17, 18).
YopM, also a virulence determinant, has homology to a
platelet glycoprotein that is a transmembrane receptor for
thrombin. Culture supernatants containing YopM have been
shown to competitively bind thrombin and inhibit platelet
aggregation in vitro (19, 20). However, YopM has also been
shown to be translocated into mammalian cells, where its
function is unknown (21). YpkA (also called YopO in 
 
Y
 
.
 
enterocolitica
 
) is a serine/threonine protein kinase that has
been shown to cause morphological changes in cultured
mammalian cells, presumably interfering with host cell sig-
nal transduction cascades (22, 23). A nonpolar 
 
ypkA
 
 mutant
is attenuated in the mouse model of infection (22).
Recently, studies have shown that programmed cell death,
apoptosis, is triggered in host cells in response to in vitro in-
fection by a variety of extra- and intracellular bacterial
pathogens (24–27). Apoptosis is an innate cell suicide mech-
anism that plays a role in homeostasis in multicellular organ-
isms and may play a role in some infectious diseases (28).
Pathogens can cause apoptosis by a variety of mechanisms
including inhibition of host cell protein synthesis by bacterial
A-B toxins, disruption of membrane integrity by pore-form-
ing hemolysins, and activation of the caspase IL-1
 
b
 
 convert-
ing enzyme (ICE) by IpaB from 
 
Shigella 
 
(27, 29). 
 
Yersinia
 
also triggers programmed cell death in cultured macrophages
(30–32). YopJ (YopP in 
 
Y
 
.
 
 enterocolitica
 
), another 
 
Yersinia
 
-
secreted protein, is necessary for inducing apoptosis of mac-
rophages in vitro (31, 32). The exact mechanism by which
YopJ induces apoptosis is not known, but YopJ has been
shown to effect TNF-
 
a
 
 and IL-8 production by host cells in
vitro (33–35).
The cytokines, TNF-
 
a
 
, IFN-
 
g
 
, and IL-8 play essential
roles in the proinflammatory response to bacterial infec-
tion. Studies in the murine infection model of Yersiniosis
provide evidence that Yops mediate suppression of the
production of TNF-
 
a
 
 and IFN-
 
g
 
 in vivo, and the ability of
 
Yersinia
 
 to inhibit these proinflammatory cytokines corre-
lates with enhanced replication within its host (36, 37).
Furthermore, the addition of TNF-
 
a
 
 and IFN-
 
g
 
 limits the
severity of 
 
Yersinia
 
 infection (37). In cultured macrophages,
 
Y
 
. 
 
pseudotuberculosis
 
 and 
 
Y
 
. 
 
enterocolitica
 
 promote deactiva-
tion of mitogen-activated protein kinases (MAPKs) p38
and JNK, and inhibit nuclear translocation of nuclear factor
(NF)-
 
k
 
B (33–35, 38). The production of YopJ correlates
with TNF-
 
a
 
 suppression, inhibition of NF-
 
k
 
B, and apop-
tosis in cultured macrophages (35, 38).
Despite the recent advancements in molecular and cellu-
lar studies on YopJ and its effects on host cells
 
 
 
in vitro, its
role in vivo
 
 
 
has not yet been characterized. In this study,
we assess the role of YopJ in virulence by calculating the
oral LD
 
50
 
 and measuring the colonization of tissues in mice
when infected either with an equal mixture of 
 
yopJ
 
 mutant
bacteria and wild-type bacteria or with the individual 
 
Yer-
sinia
 
 strains. We also measure the amount of apoptosis in
infected tissue and show that YopJ production significantly
increases the levels of apoptosis in infected tissues. We con-
clude that the ability of wild-type 
 
Yersinia
 
 to induce apop-
tosis correlates with increased bacterial replication and aids
in the establishment of a systemic infection.
 
Materials and Methods
 
Mice.
 
8–10-wk-old, female BALB/c mice were purchased
from Charles River Labs. (Wilmington, MA) and kept under spe-
cific pathogen free conditions in filter-top cages. Mice were pro-
vided with sterile water and food ad libitum.
 
Bacterial Strains.
 
Several wild-type 
 
Y
 
.
 
 pseudotuberculosis
 
 YPII-
IpYV containing random Tn5 insertions in the chromosome were
isolated and tested for virulence. The isolate, YPIIIpYV
 
Km
 
1, was
shown in a competition infection in mice to colonize PP, mesen-
teric lymph nodes (MLNs), and spleen as well as YPIIIpYV (data
not shown).
The 
 
yopJ
 
 mutant strain, YPIIIp
 
yopJ
 
, was constructed as follows:
pypkAyopJ (32) was digested with SnaBI and HpaI and ligated,
which resulted in a 1044 bp deletion spanning the start codon of
 
yopJ
 
. The resulting clone was digested with SstI and XbaI and li-
gated into the SstI and XbaI sites of a suicide vector, pCVD442
(39), containing sacB. The resulting clone, p
 
D
 
yopJ
 
, was elec-
troporated into 
 
Escherichia
 
 
 
coli
 
 SM10
 
l
 
pir
 
 and conjugated into
YPIIIpYV. Exconjugants were selected on L-agar plates contain-
ing irgasan (2 
 
m
 
g/ml) and ampicillin (100 
 
m
 
g/ml). To identify
double recombinants, the exconjugants were plated on L-agar
with 5% sucrose and single colonies were screened by PCR and
Southern blotting for the presence of the 1044 bp deletion (data
not shown). The phenotype of the resulting mutants were ana-
lyzed in a macrophage cytotoxicity assay measuring the release of
lactate dehydrogenase using the cytotox 96 kit (Promega Corp.,
Madison, WI), an In Situ Cell Death Detection Kit (Boehringer
Mannheim, Indianapolis, IN) for labeling the nicked end of DNA
in apoptotic cells, and by Western blotting (32). As expected, the
mutant strain, YPIIIp
 
yopJ
 
, did not kill the infected macrophages,
and the level of apoptosis as indicated by the TUNEL (Tdt-medi-
ated dUTP–biotin nick-end labeling) reaction was the same as
background levels for uninfected macrophages (data not shown).
The addition of 
 
yopJ
 
 on a plasmid in trans restores the ability of
the mutant strain to kill macrophages
 
 
 
in vitro (data not shown).
The growth rates of YPIIIp
 
yopJ
 
 and YPIIIpYV in 2xYT broth
were identical (data not shown).
 
Infection of Animals.
 
Bacteria were grown with aeration in
2xYT broth for 15–18 h at 26
 
8
 
C and resuspended in PBS before
inoculating mice. For LD
 
50
 
 calculations, 120 mice were inocu-
lated orogastrically, through a gastric tube, with serial 10-fold
(
 
n
 
 5 
 
10 mice/inoculum) dilutions ranging from 3 
 
3 
 
10
 
6
 
 to 3 
 
3
 
10
 
10
 
. The health of the animals was followed for 30 d after inocu-
lation, and deaths were recorded. For competition infections,
mice were inoculated orogastrically with an equal mixture of 8 
 
3
 
10
 
8
 
 YPIIIpYVKmr and 8 3 108 YPIIIpyopJ. PP, MLNs, and
spleens were homogenized in sterile stomacher bags and weighed.
Dilutions of homogenized tissues were plated on L-agar plates
either with or without kanamycin (40 mg/ml) to obtain bacterial
counts per gram of tissue (CFU on plain L-agar 2 CFU on
L-agar with kanamycin 5 CFU YPIIIpyopJ).
Flow Cytometry. Single-cell suspensions of MLNs and spleens
were prepared by homogenizing tissue in 1.5 ml PBS containing2129 Monack et al.
5% FCS with the rubber end of a syringe plunger. An aliquot
from each sample was plated on L-agar to assess bacterial load in
the tissue. Debris was removed by passing cells through a cell
strainer cap with a 35-mm mesh screen (Falcon Labs., Cock-
eysville, MD). Approximately 2 3 106 cells per organ from each
mouse of each group were stained with a 1:100 dilution of anti–
mouse CD11b Mac-1–biotin antibody (Caltag Labs., San Fran-
cisco, CA) (40) for 30 min at 48C. The cells were fixed with 4%
paraformaldehyde for 30 min at room temperature, washed with
1 ml of PBS, and permeabilized with 0.1% Triton X-100 in 0.1%
sodium citrate for 2 min on ice and washed with 1 ml of PBS.
Cells were then labeled with the TUNEL reaction mixture for
1 h at 378C, labeled with a 1:100 dilution of streptavidin-PE (Cal-
tag Labs.) for 30 min at room temperature and resuspended in 500
ml PBS for analysis by flow cytometry. From each sample, 50,000–
100,000 cells were analyzed by flow cytometry with a FACScanÒ
and FACScanÒ software (Becton Dickinson, San Jose, CA).
Histology and TUNEL Reactions on Fixed Tissue. For histolog-
ical examinations and TUNEL reactions on tissue sections, PP,
MLNs, and spleens were fixed in 10% buffered neutral formalin,
embedded in paraffin, and cut. Some sections were then stained
with hematoxylin and eosin. Sections for TUNEL reactions were
processed as described for the In Situ Cell Death Detection Kit,
Fluorescein (Boehringer Mannheim Biochemicals). In brief, tis-
sue sections were heated at 608C for 30 min followed by washing
in xylene and rehydration through graded series of ethanol and
redistilled water. Sections were treated with proteinase K (20 mg/
ml in 10 mM Tris-HCL, pH 7.4) for 30 min at room tempera-
ture, washed, and overlaid with premixed TUNEL reaction mix-
ture. The sections were labeled for 1 h at 378C, washed with
PBS, incubated in anti-Yersinia polyclonal rabbit antiserum, and
finally incubated with anti–rabbit-TRITC antibody (Sigma Chemi-
cal Co., St. Louis, MO). Coverslips were mounted over anti-
quench and sealed, and tissue sections were analyzed on a fluores-
cence microscope.
Statistical Analysis. The paired differences of CFU g21 be-
tween the yopJ mutant and wild-type strains for each animal were
compared by the paired t test and Mann Whitney U test. The
mean percentage of Mac-11 cells that were TUNEL1 for cells
isolated from MLNs and spleens were compared by the t test.
Results
YPIIIpyopJ Is Attenuated in the Oral Mouse Model. To
assess the role of YopJ in Yersinia virulence, we determined
the oral LD50 in a susceptible strain of mice. 10 BALB/c
mice per bacterial strain were inoculated with serial 10-fold
dilutions of wild-type Y. pseudotuberculosis, YPIIIpYV, or of
the isogenic yopJ mutant Y. pseudotuberculosis, YPIIIpyopJ.
The infected animals were followed for 30 d and the esti-
mated value for the 50% death point was calculated by the
Reed-Muench method (41). The calculated LD50 for the
mutant strain, YPIIIpyopJ, was 1.59 3 109, which is 64-
fold higher compared with the calculated LD50 for wild-
type Y. pseudotuberculosis, YPIIIpYV, 2.49 3 107. This indi-
cated that YopJ is a virulence factor in the mouse model of
infection.
Wild-type Y. pseudotuberculosis Out-competes the yopJ Mu-
tant in a Mixed Infection in Mice. To assess where in the
course of the infection the activity of YopJ becomes im-
portant for the establishment of Yersiniosis, we first looked
at the ability of the yopJ mutant to survive in the presence
of competing wild-type bacteria. 30 mice were infected
orogastrically with an equal mixture of wild-type Y.
pseudotuberculosis, Kmr and yopJ mutant Y. pseudotuberculosis.
Recoverable bacteria were obtained on days 1, 2, 3, 4, and
5 after inoculation from cecum, PP, MLNs, and spleens
and plated on L-agar with or without kanamycin. Both
bacterial strains were recovered in equal numbers from the
cecum and PP on days 1–5 (Table 1). At 2 d after inocula-
tion, the wild-type Y. pseudotuberculosis strain was recovered
in higher numbers from the MLNs, and the mean paired
difference was 2.47 6 0.74 logs (Table 1). The wild-type
strain continued to out-compete the yopJ mutant strain on
days 3, 4, and 5 with the mean paired differences being
1.66 6 0.75, 1.67 6 0.76, and 0.97 6 0.18 logs, respec-
tively. Yersinia was first observed in the spleens of infected
mice on day 3. At 3 d after inoculation, the wild-type strain
colonized the spleen in greater numbers, with a mean
paired difference of 2.68 6 0.83 logs. This 100-fold differ-
ence between the wild-type strain and the yopJ mutant
strain remained similar on days 4 and 5 after inoculation,
with mean paired differences of 2.39 6 0.76 and 1.95 6
0.66 logs, respectively (Table 1). The P values for the mean
paired differences in the MLNs and spleen were ,0.05 and
thus were significant (Table 1). These data suggest that the
yopJ mutant bacteria were defective in their ability to
spread from the PP to the MLNs and then to the spleen.
Table 1. Wild-type Yersinia out-competes yopJ Mutant in 
Colonization of MLNs and Spleens
Tissue Day Log mean difference 6 SD* P value‡
Cecum 1 20.37 6 0.45
2 3.56 6 1.29 0.0399
3 1.70 6 1.52
4 2.71 6 1.52
5 0.09 6 0.16
PP 1 20.03 6 0.25
2 2.73 6 1.38
3 1.43 6 1.17
4 1.73 6 1.46
5 0.33 6 0.19
MLN 2 2.47 6 0.74 0.0204
3 1.66 6 0.75 0.0404
4 1.66 6 0.76 0.0500
5 0.97 6 0.18 0.0029
Spleen 3 2.68 6 0.83 0.0481
4 2.39 6 0.76 0.0254
5 1.95 6 0.66 0.0319
*Difference 5 Log YPIIIpYV CFU g212Log YPIIIpyopJ CFU g21.
‡P value is from paired two group t test and is only given when
#0.0500.2130 YopJ-dependent Apoptosis in Yersinia Infection
A yopJ Mutant Does Not Colonize Spleens as Well as a
Wild-type. To determine where in the course of infection
the yopJ mutant was attenuated in the absence of competing
wild-type bacteria, we infected mice with two different
doses of YPIIIpYV or YPIIIpyopJ. In an initial experiment,
the mice were inoculated with 2 3 108 wild-type strain or
yopJ mutant strain, and recoverable bacteria were quanti-
tated. All of the mice inoculated with wild-type bacteria
were colonized in all tissues tested with the mean log CFU
g21 increasing 2.7-fold in the MLNs from day 4 to day 5 af-
ter infection (Table 2). The mean CFU g21 spleen increased
16-fold from day 4 to day 5. YPIIIpyopJ bacteria were
recovered from the cecum of all mice inoculated with the
mutant strain; however, the mean CFU g21 cecum was
40-fold less than the mean CFU g21 cecum infected with
wild-type bacteria (Table 2). Although we recovered bacte-
ria from the PP of three out of the five mice inoculated
with the yopJ mutant bacteria 4 d after infection, the CFU
g21 PP were lower than the mean CFU g21 PP from mice
infected with wild-type bacteria. We recovered an average
of 3.2 3 104 CFU g21 MLNs from the three mice that con-
tained yopJ mutant bacteria in the PP, and we did not re-
cover any bacteria from the MLNs of those mice that did
not have any bacteria in the PP. Only one of the five mice
infected with the yopJ mutant strain had any viable bacteria
in the spleen, with 4.56 3 102 CFU g21. By day 5, only
two of the five mice infected with the yopJ mutant bacteria
contained viable bacteria in the PP and MLNs, and only
one of these mice contained bacteria in the spleen. Thus, the
inoculation of mice with wild-type Y. pseudotuberculosis at a
dose that is 10-fold higher than the LD50 resulted in uni-
formly high levels of infection in the tissues tested. In striking
contrast, the inoculation of mice with the same dose of the
yopJ mutant strain resulted in very few of the animals show-
ing signs of infection 4 and 5 d after inoculation (Table 2).
To extend these results, mice were infected with higher
bacterial doses. 25 mice were inoculated with 109 wild-
type YPIIIpYV and 25 mice were inoculated with 109
Table 2. Colonization of Mice Inoculated Orally with 2 3 108 Wild-type or yopJ Mutant Y. pseudotuberculosis
Strain Animal Cecum PP MLN Spleen
Day 4
YPIIIpYV 1 8.20 3 107 5.21 3 106 6.69 3 102 1.52 3 103
2 6.32 3 106 3.56 3 105 4.21 3 105 1.10 3 102
3 6.93 3 106 3.62 3 107 3.16 3 103 7.35 3 103
4 6.62 3 107 1.56 3 107 7.79 3 103 1.89 3 103
5 5.21 3 107 3.26 3 106 5.10 3 104 5.14 3 104
mean 4.27 3 107 1.21 3 107 9.67 3 104 1.25 3 104
YPIIIpyopJ 1 2.23 3 105 3.32 3 103 2.25 3 104 0.00
2 6.53 3 102 ,10 0.00 0.00
3 2.25 3 106 4.38 3 102 0.00 0.00
4 5.64 3 102 ,10 0.00 0.00
5 5.23 3 105 2.25 3 104 7.56 3 104 4.56 3 102
mean 5.99 3 105
Day 5
YPIIIpYV 1 7.70 3 106 6.00 3 104 3.26 3 104 1.55 3 104
2 5.63 3 106 3.73 3 105 4.89 3 104 8.42 3 104
3 1.21 3 107 1.08 3 105 1.61 3 105 4.50 3 105
4 3.93 3 106 3.27 3 105 9.08 3 105 1.65 3 105
5 5.20 3 107 1.04 3 107 1.36 3 105 2.62 3 105
mean 1.63 3 107 2.25 3 106 2.57 3 105 1.95 3 105
YPIIIpyopJ 1 8.34 3 106 ,10 0.00 0.00
2 7.70 3 102 ,10 0.00 0.00
3 6.68 3 102 ,10 0.00 0.00
4 1.62 3 105 3.69 3 103 3.47 3 102 0.00
5 1.41 3 106 5.18 3 104 1.02 3 105 3.58 3 103
mean 1.98 3 106
Values are CFU g21 recovered from various tissues.2131 Monack et al.
YPIIIpyopJ. Bacteria were recovered from PP, MLNs, and
spleens on days 2, 3, 4, and 5 after inoculation. There was
no difference in the ability of wild-type bacteria and yopJ
mutant bacteria to colonize the PP (data not shown). In
contrast to the mixed infection experiments, the yopJ mu-
tant bacteria colonized the MLNs as well as wild-type bac-
teria at these high challenge doses in the absence of com-
peting wild-type bacteria (Fig. 1). However, in the spleen
the yopJ mutant never reached the same levels as wild-type
bacteria. At 4 d after inoculation the mean log CFU g21 for
the yopJ mutant was 4.11 6 0.43, whereas the mean log
CFU g21 spleen infected with wild-type was 5.07 6 0.22
(P 5 0.0500; Fig. 1). 5 d after inoculation the number of
yopJ mutant bacteria recovered from the spleens decreased
to 3.44 6 0.66 log CFU g21, whereas the number of wild-
type bacteria increased to 5.75 6 0.09 (P 5 0.0100; Fig. 1).
Thus, the yopJ mutant is unable to sustain growth in spleens
of infected mice.
Flow Cytometry Indicates that Yersinia Induces YopJ-depen-
dent Apoptosis In Vivo. YopJ is necessary for the ability of
Yersinia to induce apoptosis in macrophages in vitro (31).
To date there has not been any in vivo evidence demon-
strating that Yersinia causes apoptosis during an infection or
that the ability to induce apoptosis is important in Yersinia
pathogenesis. To correlate Y. pseudotuberculosis virulence in
mice with the ability of Yersinia to induce programmed cell
death in cultured macrophages, we measured the levels of
apoptosis in tissues infected with 8 3 108 wild-type or 5 3
109 yopJ mutant bacteria. Inoculating mice with higher num-
bers of yopJ mutant bacteria resulted in more viable bacteria
recovered, and thus allows us to rule out a nonspecific effect
of bacterial load in our analysis of Yersinia-induced apoptosis
in vivo. At days 4 and 5 after inoculation, PP, MLNs, and
spleen were harvested and single cell suspensions were pre-
pared for stainings and flow cytometry. Apoptosis was mea-
sured by the TUNEL reaction where nuclei containing
DNA fragmentation were labeled with dUTP-FITC by the
enzyme TdT for detection by flow cytometry. Cells were
also stained with a biotinylated Mac-1 antibody, an antibody
that recognizes the CR3 receptor on macrophages, poly-
morphonuclear cells, dendritic cells, and a subset of natural
killer cells. Mac-1 cells were then labeled with streptavidin-
PE for detection by flow cytometry.
The overall percentage of cells isolated from uninfected PP
that were TUNEL positive was relatively high and extremely
variable (5.25–45.10%; data not shown). However, there
was no significant difference in the percentage of TUNEL-
positive cells or Mac-11 cells that were TUNEL positive be-
tween infected PP and uninfected PP (data not shown).
Two distinct Mac-11 cell populations were observed
based on their forward scatter. The population in gate R1
has a forward scatter consistent with that of macrophages
and excludes cell debris (Fig. 2; references 42, 43). The
mean percentage of gate R1 cells from YPIIIpYV-infected
Figure 1. The yopJ mutant does not colonize spleens as well as wild-
type Y. pseudotuberculosis. Colonization kinetics from mice infected orally
with 109 YPIIIpYV or 109 YPIIIpyopJ. Log CFU g21 MLNs or spleen for
YPIIIpYV, and YPIIIpyopJ, on days 2, 3, 4, and 5 after inoculation are
shown (n 5 6 mice/strain for each time point). Curve for YPIIIpYV colo-
nization is a solid line. Curve for YPIIIpyopJ colonization is a dashed line.
Figure 2. An increase in the number of TUNEL-positive cells in in-
fected tissues correlates with YopJ production. Flow cytometry analysis of
single cell suspensions prepared from spleens infected for 4 d with (A)
YPIIIpYV (n for R1 5 1006) or (B) YPIIIpyopJ (n for R1 5 1546), or
(C) from uninfected mice (n for R1 5 2255). TUNEL-positive cells were
detected in FL1 and cells immunostained with Mac-1 antibody were de-
tected in FL2. Gates were drawn around three populations of cells. R1
represents a population of cells that were stained with Mac-1 antibody
and had a mean forward scatter of 170. R2 represents a population of cells
that also stained with Mac-1 antibody and had a mean forward scatter of
350. R3 represents a population of cells that were specifically labeled in
the TUNEL reaction and had a positive signal in FL1 relative to negative
controls. Percentages indicate the percentage of cells within the gate R1
cell population that were TUNEL positive.2132 YopJ-dependent Apoptosis in Yersinia Infection
MLNs and spleens that were TUNEL positive on day 4 af-
ter inoculation was 9.85 6 4.20 and 12.08 6 4.12, respec-
tively (Table 3). These levels increased in YPIIIpYV-
infected MLNs and spleens to 21.41 6 4.96 and 27.82 6
5.40, respectively, on day 5 after inoculation (Table 3). Al-
though the CFU recovered from MLNs and spleens in-
fected with YPIIIpYV or YPIIIpyopJ were similar (Table
3), the percentage of the Mac-11 cells within gate R1 from
tissues infected with wild-type bacteria that were TUNEL
positive was 5–10-fold higher than the percentages ob-
tained from tissues infected with the yopJ mutant. The per-
centage of the total cell population or of gated Mac-11 cells
that were TUNEL positive isolated from MLNs and spleens
infected with the yopJ mutant was never significantly
greater than the background level obtained for cells isolated
from uninfected control MLNs and spleens (Table 3).
Thus, YopJ production correlates with the induction of
apoptosis in a population of Mac-11 cells that includes
macrophages in infected MLNs and spleens.
The Mac-11 population of cells within gate R2 had
higher forward scatter values and are most likely polymor-
phonuclear and dendritic cells (Fig. 2; references 42, 43).
When we analyzed this second population of cells, we did
not observe a significant difference in the percentage of
TUNEL-positive cells from tissue infected with either bac-
terial strain compared with uninfected tissue. We conclude
that there appears to be a distinct Mac-1 population of cells
that is targeted by Yersinia in vivo.
Does the eventual reduction in the recovery of viable
yopJ mutant bacteria in the spleen correlate with an increase
of phagocytic cells that could kill the bacteria? To address
this we analyzed the entire population of cells that stained
with the Mac-1 antibody (Fig. 2). The recruitment of
Mac-11 cells to MLNs infected with YPIIIpYV or YPII-
IpyopJ was significant on day 5 after inoculation, with an
increase from 2 to 4% of the total population (Table 3).
The increase of Mac-11 cells in spleens infected with YPI-
IIpyopJ was most noticeable at 5 d after inoculation with
12% of the total cell population staining with the Mac-1
antibody compared with 6% for uninfected spleens. In con-
trast, the percentage of Mac-11 cells from spleens infected
with YPIIIpYV remained the same as that of uninfected
spleens (Table 3). Thus, the increase in the relative per-
centage of cell types capable of producing proinflammatory
cytokines as well as phagocytosing and subsequently killing
the yopJ mutant may be responsible for the eventual elimi-
nation of the bacteria (Fig. 1).
Histologic Studies Show Yersinia-induced Apoptosis In Vivo.
To further characterize abscesses observed in infected tis-
sues, fixed sections of tissue from three mice inoculated
orogastrically with 5 3 109 YPIIIpYV or three mice inoc-
ulated with 5 3 109 YPIIIpyopJ were stained with hema-
toxylin and eosin. Infection with both wild-type and yopJ
mutant bacteria resulted in the recruitment of phagocytes
to MLNs and spleens (days 1–2) and the subsequent forma-
tion of abscesses. These abscesses had a central region com-
Table 3. Increase in TUNEL1 Mac-11 Cells from Tissue of Mice Infected with Wild-type Y. pseudotuberculosis Bacteria
Tissue Bacterial strain
Percentage of
gate R1, TUNEL1
cells 6 SE* P value‡
Percentage of
Mac-11 6 SE§ P value¶
Mean CFU
recovered
Day 4
MLN YPIIIpVY 9.85 6 4.20 3.38 6 0.36 2.42 3 103
MLN YPIIIpyopJ 2.14 6 0.78 2.62 6 0.41 2.48 3 103
Spleen YPIIIpYV 12.08 6 4.12 4.97 6 1.38 5.13 3 102
Spleen YPIIIpyopJ 2.17 6 0.47 7.10 6 0.92 3.13 3 102
Day 5
MLN YPIIIpYV 21.41 6 4.96 0.0013 3.95 6 0.25 0.0161 4.45 3 103
MLN YPIIIpyopJ 2.01 6 0.37 3.74 6 0.36 0.0434 1.33 3 103
Spleen YPIIIpYV 27.82 6 5.40 0.0002 5.86 6 1.05 3.94 3 103
Spleen YPIIIpyopJ 2.14 6 0.33 12.32 6 1.42 0.0167 2.25 3 103
MLN Uninfected 3.45 6 1.41 1.91 6 0.89
Spleen Uninfected 1.74 6 0.55 5.96 6 0.92
*Mac-1 (M1/70) antibody conjugated to biotin was used to stain single cell suspensions. Streptavidin-PE was detected in FL-2. Cells within gate R1
were analyzed to obtain the percentage of Mac-11 cells with a forward scatter in the range of monocytes or macrophages that were TUNEL positive.
n 5 9 mice per inoculum/day, n 5 5 uninfected mice.
‡P values are from a t test comparing percentage of gate R1, Mac-11 cells that were also TUNEL positive obtained for YPIIIpYV-infected tissue
compared to values obtained for YPIIIpyopJ-infected tissue. Values only given when P # 0.0500.
§The relative percentage of Mac-11 cells was obtained by gating on cells positive in FL-2. Cell debris was gated out.
¶P values are from a t test comparing percentage Mac-11 cells obtained for either YPIIIpYV-infected tissue or YPIIIpyopJ-infected tissue to values
obtained for uninfected tissue. Values only given when P # 0.0500.2133 Monack et al.
posed of cells with the morphological features of poly-
morphonuclear cells and a distinct border made up of
predominantly large mononuclear cells (days 3–5). Often
more cell debris and pyknotic/apoptotic cells were associ-
ated with abscesses from MLNs or spleen infected with
wild-type Y.  pseudotuberculosis compared with tissue in-
fected with the yopJ mutant strain (Fig. 3).
To determine which cells were apoptotic, TUNEL reac-
tions were performed on sections from the same MLNs
that were stained for histology (Fig 3). Bacteria were
stained with an anti-Yersinia antibody followed by a sec-
ondary antibody-rhodamine conjugate. There was a dra-
matic increase in the number of TUNEL-positive cells in
the MLNs infected for 3 d with wild-type bacteria com-
pared with MLNs infected for 3 d with the yopJ mutant
(Fig. 4). The microscopic data on fixed tissue sections com-
bined with the flow cytometry data support the conclusion
that the presence of YopJ correlates with an increase in
apoptotic cells and that bacteria lacking YopJ are more
likely to be cleared from infected tissues.
Discussion
Previously we and others have shown that YopJ is re-
quired for Yersinia-induced apoptosis in macrophages in
vitro (30–32). In this study, we report that a Y. pseudotuber-
culosis strain that no longer makes YopJ is significantly at-
tenuated in the mouse model of a systemic Yersinia infec-
tion with an almost 100-fold increase in the oral LD50 over
wild-type Y. pseudotuberculosis in BALB/c mice. Thus, YopJ
is a virulence factor. Two previous publications on mouse
infections with yopJ mutants indicated that YopJ is not a
virulence factor (44, 45). Galyov et al. challenged three
mice orally with high undefined doses of either wild-type
or yopJ mutant Y. pseudotuberculosis strains and reported that
all mice died within 6 d of infection (45). Our data are not
inconsistent with these results given that a high dose of the
yopJ mutant did result in the death of some of our infected
mice. Straley and Bowmer measured the LD50 of a Y. pestis
yopJ mutant injected intravenously into Swiss mice and
found that the LD50 values for the yopJ mutant and wild-
type were similar (44). It is possible that a yopJ mutant is
not as attenuated in Y. pestis or in Swiss mice, or that the
mode of inoculation plays a role in bacterial virulence.
To investigate at what stage of a systemic Yersinia infec-
tion YopJ might be playing a role in virulence, we first
tested the yopJ mutant in a competition infection in mice.
To this end, mice were inoculated with an equal mixture
of the wild-type bacterial strain and the isogenic yopJ mu-
tant bacterial strain. Although the wild-type and yopJ mu-
tant strains were recovered in equal numbers from the
cecum and PP, 500-fold more wild-type bacteria than yopJ
mutant bacteria were recovered from infected MLNs 2 d
after inoculation. The selective advantage that YopJ confers
on Yersinia is also reflected in the subsequent spread to the
spleen, where wild-type had 500-fold more colonies than
the yopJ mutant. A similar difference was seen in the spleens
of mice infected with the individual bacterial strains. We
propose that YopJ does not play a role in the ability of Yer-
sinia to enter the PP or to replicate within the PP. Rather,
we believe that early in the infectious process, the bacteria
making YopJ have a selective advantage in seeding and col-
onizing the MLNs due to their ability to kill activated mac-
rophages by apoptosis.
To determine if the ability of wild-type Yersinia to cause
a systemic infection correlates with the ability to induce
apoptosis in macrophages in vivo, we quantitated the level
of apoptosis by flow cytometry from tissues infected with
either the wild-type bacteria or the yopJ mutant bacteria.
There was a significant increase in the number of TUNEL-
positive cells in the R1 subset of Mac-11 cells from MLNs
and spleens infected with wild-type bacteria. In contrast,
the levels of TUNEL-positive cells in the Mac-11 cells
within gate R1 or even in the total cell population from
Figure 3. Histology shows cells with condensed nuclei in MLNs in-
fected with wild-type Yersinia. Hematoxylin and eosin staining of fixed
MLNs infected with 5 3 109 YPIIIpYV or YPIIIpyopJ for 3 days. (a) This
photomicrograph shows an abscess typical of the inflammation seen in
mice infected with wild-type Yersinia. (b) At higher magnification note the
predominance of condensed nuclei and pyknotic cell debris, (arrowheads)
typical of apoptotic cells. (c) Typical lymph node abscess seen in mice in-
fected with the yopJ mutant strain which at higher magnification (d) shows
numerous viable inflammatory cells (arrows) that maintain their nuclear
morphology. Original magnifications: a and c, 3100; b and d, 3250 oil.2134 YopJ-dependent Apoptosis in Yersinia Infection
MLNs and spleens infected with the yopJ mutant bacteria
was never significantly greater than the levels found in cells
from uninfected tissues. These results indicate that the pro-
duction of YopJ correlates with an increase in apoptosis
in vivo and that Yersinia-induced apoptosis probably plays
a role in establishing a systemic infection. We also analyzed
a second Mac-11 cell population (Fig. 2, gate R2) with a
higher forward scatter, and found that the percentage of
these cells that were TUNEL positive did not increase
when infected with wild-type bacteria. This population of
Mac-11 cells is likely to be polymorphonuclear lympho-
cytes, dendritic cells, and perhaps some macrophages (42).
Previous studies focusing on host defense mechanisms
against Yersinia infection have implicated both T cells and
macrophages, and their secretion of the cytokines TNF-a,
IFN-g, and IL-12 as essential components in protective
host responses against Yersinia (37, 46–50). Although we
did not stain with antibodies that recognize macrophages
exclusively, the forward scatter profile indicates that the
population of cells that show an increase in the percentage
of TUNEL-positive cells is likely to be macrophages. We
suggest that the macrophage is being targeted and killed in
the host during Yersinia infection by YopJ. Autenrieth et al.
have shown that the administration of Mac-1 antibodies
before Yersinia infection caused increased bacterial numbers
in the PP and MLNs (51). Therefore, the ability of wild
type Yersinia to neutralize a primary host immune cell, the
macrophage, gives the bacterial pathogen a distinct advan-
tage in its ability to cause a systemic infection.
We noticed a population of cells that did not stain with
the Mac-1 antibody yet were TUNEL positive in tissues
from animals infected with wild-type Yersinia. It is possible
that the Mac-1 antibody did not stain the dying cells in this
population because they no longer express the CR3 recep-
tor. The forward scatter of these cells was slightly lower
than the forward scatter of the gate R1 population of cells
that showed the increase in TUNEL-positive cells when
infected with wild-type bacteria. The decrease in the for-
ward scatter of these cells could be due to cell shrinkage as-
sociated with cells undergoing apoptosis. Alternatively, the
cells within this population could include T cells, which
have been shown to be important for limiting Yersinia in-
fections in mice (49). The possibility that a cell population
other than macrophages is being killed by Yersinia in vivo is
intriguing in light of results reported by Ruckdeschel et al.
(38). They provide data that Yersinia infection in vitro con-
fers susceptibility to programmed cell death to cell types
other than macrophages (epithelial cells), provided that the
appropriate death signal is delivered. Perhaps the ability of
wild-type Yersinia to promote apoptosis in vivo of epithelial
cells or B or T cells is important in pathogenesis.
Recent reports have correlated the production of YopJ
(YopP in Y. enterocolitica) with both the suppression of
TNF-a and the ability to induce apoptosis in macrophages
by Yersinia (33, 34, 38). We propose that our in vivo results
are consistent with the in vitro YopJ phenotype of the sup-
pression of TNF-a production by macrophages. The result
that wild-type bacteria out-compete the yopJ mutant in
spreading from the PP to the MLNs suggests that the ability
of Yersinia to kill macrophages early in the infection gives
the bacteria an advantage in colonizing the deeper tissues,
such as MLNs and spleens. This is further supported by our
results that, in spleens infected with the yopJ mutant bac-
teria, we see a recruitment of Mac-11 cells that are pre-
Figure 4. TUNEL reactions
show an increase in apoptosis in
MLNs infected with wild-type
Y. pseudotuberculosis. Sections
from the same fixed tissues used
for histology were processed as
described in Materials and Meth-
ods, permeabilized, and subjected
to the TUNEL reaction. Nuclei
of apoptotic cells in tissue in-
fected with either (a) wild type
Yersinia or (b)  yopJ mutant Yer-
sinia, were detected with an FITC
filter on an epifluorescent micro-
scope (arrows). The presence of
TUNEL-positive nuclei in MLNs
from the mouse infected with the
yopJ mutant was similar to the
background level of apoptosis
seen in MLNs from uninfected
mice. Bacteria were detected
with an anti–Y. pseudotuberculosis
antibody and a secondary TRITC-
conjugated antibody with a rho-
damine filter. Original magnifi-
cation:  3640.2135 Monack et al.
sumably clearing the bacterial infection. Recruitment of
Mac-11 cells suggests the production of a proinflammatory
cytokine such as TNF-a in vivo. Preliminary results ob-
tained from TNF-a ELISA assays performed on serum
from infected mice did not show any differences in the se-
rum levels of TNF-a between mice infected with wild-
type or yopJ mutant bacteria compared with levels detected
in uninfected mice. Could the levels of proinflammatory cy-
tokines within the bacterial microenvironment ultimately
decide the fate of the bacterial infection? Studies addressing
this question are underway.
Clearly our data indicate that YopJ is playing a role in
Yersinia pathogenesis. We believe that the ability of wild-
type Yersinia to kill one of the host’s first lines of defense,
macrophages, gives the bacteria an advantage early in the
infection upon first contact with host immune cells. Addi-
tionally, the ability to suppress the production of the proin-
flammatory cytokines, TNF-a and IL-8 perhaps as well as
other as yet unidentified cytokines may allow the Yersinia
to spread to deeper tissue such as MLNs and spleens and
replicate within the deeper tissues of the host.
Although cell necrosis is a powerful stimulus for inflam-
mation, apoptosis is a mechanism of cell death in which the
cell initiates its own signal transduction pathways to cause
its own demise, and in most cases the release of proinflam-
matory cellular contents and cytokines is suppressed (52).
However, evidence from recent studies with Shigella flex-
neri, an enteric pathogen, have indicated that during infec-
tion with Shigella bacterial-induced apoptosis functions as a
trigger for inflammation through the release of proinflam-
matory cytokines (53). The virulence plasmid-encoded
protein, IpaB, induces apoptosis by interacting with IL-1b
converting enzyme (ICE), which plays two roles. One is to
initiate the apoptotic pathway and the other is to convert
IL-1b to its mature, biologically active form, which is then
released and initiates an acute inflammatory response (54).
The role of the ability of Shigella to induce this acute in-
flammatory response is postulated to be aiding in the spread
of Shigella through the basolateral surfaces of the intestinal
epithelium (28, 55). Thus, in contrast to the in vivo role of
Shigella-induced apoptosis, the role of Yersinia-induced
apoptosis is to reduce the inflammatory response in infected
tissues and thereby allow the bacteria to replicate extracel-
lularly.
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